Saturday, November 21, 2015 12:44:56 PM
Been watching this stock for just a few months.
Seems to me the science is doable and all three clinical candidates seem to have activity with great safety.
Just listened to the last conference webcast and seems the next potential inflection point is going to be in January when more data on Archexin comes out. Also if all goes well, Supinoxin & 3117 Phase II early next year.
At 0.41 PPS seems a good time to get in too, however expecting investors with itchy feet to keep making small sales until we get closer to the Jan data readout.
One question I have for those that have been here for longer than myself. I see that there has been discussion of the potential R/S.
1. Do we think this is likely to happen?
2. When would this be expected to happen? Is there an expiration on when the R/S can happen?
Hope this finds everyone well and looking forward to further discussions on this board.
Spidey
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM